A multi-omics integrative analyses reveals CYBB-mediated apoptotic and immune dysregulation as a key target of berberine in diffuse large B-cell lymphoma.

Tan J, Xu Y, He Y, Chen C, Luo J, Zhang C, Zhong J, Xiong D

Open source

DOI
10.3389/fphar.2026.1870435
Published
2026
Container
Frontiers in pharmacology
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2026.1870435,
  title = {A multi-omics integrative analyses reveals CYBB-mediated apoptotic and immune dysregulation as a key target of berberine in diffuse large B-cell lymphoma.},
  author = {Tan J and Xu Y and He Y and Chen C and Luo J and Zhang C and Zhong J and Xiong D},
  year = {2026},
  journal = {Frontiers in pharmacology},
  doi = {10.3389/fphar.2026.1870435},
  url = {https://doi.org/10.3389/fphar.2026.1870435}
}

RIS

TY  - JOUR
TI  - A multi-omics integrative analyses reveals CYBB-mediated apoptotic and immune dysregulation as a key target of berberine in diffuse large B-cell lymphoma.
AU  - Tan J
AU  - Xu Y
AU  - He Y
AU  - Chen C
AU  - Luo J
AU  - Zhang C
AU  - Zhong J
AU  - Xiong D
PY  - 2026
JO  - Frontiers in pharmacology
DO  - 10.3389/fphar.2026.1870435
UR  - https://doi.org/10.3389/fphar.2026.1870435
ER  - 

APA

J, T., Y, X., Y, H., C, C., J, L., C, Z., J, Z., & D, X. (2026). A multi-omics integrative analyses reveals CYBB-mediated apoptotic and immune dysregulation as a key target of berberine in diffuse large B-cell lymphoma.. Frontiers in pharmacology. https://doi.org/10.3389/fphar.2026.1870435

Source records